LPA and myocardial infarction: High Lp(a) levels are associated with accelerated progression of low-attenuation atherosclerotic plaques in patients with coronary artery disease, which may be associated with residual risk of myocardial infarction (MI) despite treatment with lipid-lowering therapy [20].